Sign In
Buy BHC
$4.95
-0.0600 (-1.20%)
At Close: Jun 03, 2026
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
07:07am, Wednesday, 26'th Mar 2025
U.S. stock futures were lower this morning, with the Dow futures falling around 50 points on Wednesday.
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes
02:00pm, Tuesday, 25'th Mar 2025
LAVAL, QC / ACCESS Newswire / March 25, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced that it has priced its previously announced offering
Bausch Health Announces Conditional Redemption of Senior Notes
04:15pm, Friday, 21'st Mar 2025
LAVAL, QC / ACCESS Newswire / March 21, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced that (i) it has delivered conditional notices of rede
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes
11:45am, Wednesday, 19'th Mar 2025
LAVAL, QC / ACCESS Newswire / March 19, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced that it has launched an offering (the "Offering") of
Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities
11:45am, Wednesday, 19'th Mar 2025
Transaction is part of a broader refinancing initiative aimed at opportunistically accessing capital markets to address near- and mid-term maturities LAVAL, QC / ACCESS Newswire / March 19, 2025 / Bau
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan
09:25am, Friday, 14'th Mar 2025
LAVAL, QC / ACCESS Newswire / March 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver bett
Bausch + Lomb: Solid 2024 Results, But Let's Address The Elephant In The Room
01:33pm, Friday, 21'st Feb 2025
Bausch + Lomb reported solid Q4 and full-year 2024 earnings, with CEO Brent Saunders highlighting positives while avoiding the critical issue of Bausch Health's potential sale of its 88% stake. The co
Bausch Health Q4 Earnings Recap (Reiterating Buy Rating)
06:01pm, Thursday, 20'th Feb 2025
Bausch Health reported strong Q4 results with a 6.2% Y/Y revenue increase and positive net income, driving a 10% stock rally. Key growth drivers include Salix, Xifaxan, and Solta, with a focus on long
Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales
02:30pm, Thursday, 20'th Feb 2025
BHC's fourth-quarter adjusted earnings and revenues beat estimates driven by Xifaxan. The guidance for 2025 is positive.
Compared to Estimates, Bausch (BHC) Q4 Earnings: A Look at Key Metrics
09:00pm, Wednesday, 19'th Feb 2025
Although the revenue and EPS for Bausch (BHC) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street
Bausch Health Companies Inc. (BHC) Q4 2024 Earnings Call Transcript
08:28pm, Wednesday, 19'th Feb 2025
Bausch Health Companies Inc. (NYSE:BHC ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Garen Sarafian - IR Thomas Appio - CEO Jean-Jacques Charhon - EVP & CFO Conf
Bausch Health (BHC) Q4 Earnings and Revenues Top Estimates
08:26pm, Wednesday, 19'th Feb 2025
Bausch Health (BHC) came out with quarterly earnings of $1.21 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $1.15 per share a year ago.
Bausch Health Announces Fourth Quarter and Full-Year 2024 Results
04:05pm, Wednesday, 19'th Feb 2025
Seventh consecutive quarter of year-over-year growth in both Revenue and Adjusted EBITDA (non-GAAP)1, delivering results at the high-end and/or exceeding 2024 guidance Fourth Quarter Consolidated Reve
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance
06:58am, Wednesday, 19'th Feb 2025
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its fourth-qua
What Analyst Projections for Key Metrics Reveal About Bausch (BHC) Q4 Earnings
10:20am, Monday, 17'th Feb 2025
Beyond analysts' top -and-bottom-line estimates for Bausch (BHC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter e
